Delivery Order SPE2DB24D2109-SPE2DB25FHXWM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, with a contract ceiling value of $1,727.65. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and scheduled for completion by August 8, 2025. The award represents a routine pharmaceutical supply transaction supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,738.42 on August 5, 2025, for the supply of Tamsulosin HCL 0.4 mg capsules (1,000 count). This award is non-competitive and carries a firm fixed price structure with completion targeted for August 6, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Tamsulosin HCL 0.4 mg capsules in a quantity of 1,000 units, with a ceiling value of $1,441.15. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,374.62 to AmerisourceBergen Drug Corp for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg. This non-competitive delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price pharmaceutical procurement contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, valued at $1,322.61 with firm fixed pricing. The order, issued on August 22, 2025, carries an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. Performance will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, with a ceiling value of $18,084.60. This is a firm fixed-price delivery order with no set-aside designation, meaning the contract was awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen Drug Corp's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, with a contract value of $1,192.79 and a completion date of September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical will be supplied from the vendor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg at a firm fixed price of $1,857.60, with an ultimate completion date of August 25, 2025. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $2,124.14 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Tamsulosin HCL 0.4 mg, with performance at the contractor's facility in Conshohocken, Pennsylvania. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 5, 2025. The award represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicle with DLA. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, with a contract value of $2,520.50. The award, issued on August 8, 2025, is a firm fixed price delivery order with an ultimate completion date of August 11, 2025. This is a non-set-aside, competitively awarded contract, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXWMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg at a firm fixed price ceiling value of $1,601.60. This competitive award carries no set-aside designation and requires completion by September 10, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military and federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in fulfilling federal medical procurement requirements through its extensive portfolio of competitive contract awards with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This Tamsulosin order represents a routine delivery against the company's prime IDC, supporting ongoing pharmaceutical supply needs for federal medical customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/9/25 |